Mustang Bio MBIO
NASDAQ MBIO
$0.52 -0.01 (-1.53%)
At close: Sep 10, 2026 · 4:00 PM EDT

Mustang Bio (MBIO) Other Working Capital Changes (2017 - 2026)

Mustang Bio's (MBIO) quarterly Other Working Capital Changes came in at -$2000.0 in Q2 2026, up 94.87% year-over-year from -$1026.3 in Q2 2025, and up 33.33% quarter-over-quarter from -$3000.0 in Q1 2026.

Analysis

Mustang Bio (MBIO) Other Working Capital Changes (2017 - 2026) Analysis & Trends

Mustang Bio (MBIO) has reported Other Working Capital Changes for 10 consecutive years, with -$2000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Working Capital Changes rose 94.87% year-over-year to -$2000.0 in Q2 2026; TTM through Jun 2026 was -$67000.0, a 215.52% decrease from a year earlier, with the FY2025 full-year figure at -$90000.0, up 84.64% from the prior year.
  • Other Working Capital Changes was -$2000.0 for Q2 2026 at Mustang Bio, up from -$3000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $2.0 million in Q3 2023 and troughed at -$2.8 million in Q4 2023.
  • A 5-year average of -$42611.1 and a median of -$21000.0 in 2024 frame the typical range for Other Working Capital Changes.
  • Across the five-year window, Other Working Capital Changes soared 363.87% in 2022 and tumbled 7822.22% in 2023, its largest moves.
  • Over 5 years, Other Working Capital Changes stood at $36000.0 in 2022, then plunged by 7822.22% to -$2.8 million in 2023, then surged by 104.17% to $116000.0 in 2024, then sank by 143.1% to -$50000.0 in 2025, then surged by 96.0% to -$2000.0 in 2026.
  • The last three Other Working Capital Changes figures came in at -$2000.0 (Q2 2026), -$3000.0 (Q1 2026), and -$50000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn -
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn -
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn
10 Mustang Bio 3.50 Mn 3.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,000.00
Jun 30, 2026 -2,000.00
Mar 31, 2026 -3,000.00
Mar 31, 2026 -3,000.00
Dec 31, 2025 -50,000.00
Dec 31, 2025 -50,000.00
Sep 30, 2025 -12,000.00
Sep 30, 2025 -12,000.00
Jun 30, 2025 -39,000.00
Jun 30, 2025 -39,000.00
Mar 31, 2025 11,000.00
Mar 31, 2025 11,000.00
Dec 31, 2024 116,000.00
Dec 31, 2024 116,000.00
Sep 30, 2024 -30,000.00
Sep 30, 2024 -30,000.00
Jun 30, 2024 -301,000.00
Jun 30, 2024 -301,000.00
Mar 31, 2024 -371,000.00
Mar 31, 2024 -371,000.00